Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd

NAS:TLSA (Bermuda)   Ordinary Shares
$ 0.85 +0.0597 (+7.56%) 12:41 PM EST
At Loss
P/B:
6.54
Market Cap:
$ 85.24M
Enterprise V:
$ 73.01M
Volume:
661.54K
Avg Vol (2M):
213.14K
Also Trade In:
Volume:
661.54K
At Loss
Avg Vol (2M):
213.14K

Business Description

Tiziana Life Sciences Ltd logo
Tiziana Life Sciences Ltd

ISIN : BMG889121031

Share Class Description:

TLSA: Ordinary Shares
Description
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.
Name Current Vs Industry Vs History
Cash-To-Debt 18.69
Equity-to-Asset 0.76
Debt-to-Equity 0.03
Debt-to-EBITDA -0.02
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -15.1
3-Year EPS without NRI Growth Rate -14.2
3-Year FCF Growth Rate -40.2
Name Current Vs Industry Vs History
5-Day RSI 90.55
9-Day RSI 84.59
14-Day RSI 79.19
6-1 Month Momentum % -29.33
12-1 Month Momentum % -52.55

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.85
Quick Ratio 3.85
Cash Ratio 1.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.8
Name Current Vs Industry Vs History
ROE % -93.29
ROA % -74.04
ROIC % -443.41
ROC (Joel Greenblatt) % -7764.54
ROCE % -92.6

Financials (Next Earnings Date:2024-04-26 Est.)

TLSA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TLSA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Tiziana Life Sciences Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.182
Beta 0.26
Volatility % 37.16
14-Day RSI 79.19
14-Day ATR ($) 0.085589
20-Day SMA ($) 0.525369
12-1 Month Momentum % -52.55
52-Week Range ($) 0.41 - 1.2699
Shares Outstanding (Mil) 100.31

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Tiziana Life Sciences Ltd Filings

Filing Date Document Date Form
No Filing Data

Tiziana Life Sciences Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Tiziana Life Sciences Ltd Frequently Asked Questions

What is Tiziana Life Sciences Ltd(TLSA)'s stock price today?
The current price of TLSA is $0.85. The 52 week high of TLSA is $1.27 and 52 week low is $0.41.
When is next earnings date of Tiziana Life Sciences Ltd(TLSA)?
The next earnings date of Tiziana Life Sciences Ltd(TLSA) is 2024-04-26 Est..
Does Tiziana Life Sciences Ltd(TLSA) pay dividends? If so, how much?
Tiziana Life Sciences Ltd(TLSA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1